Human bocavirus is not detectable in bone marrow from patients with myelodysplastic syndromes
نویسندگان
چکیده
from patients with myelodysplastic syndromes Verena Schildgen, Jessica Lüsebrink, Ramona Liza Tillmann, Michael Wulfert, Norbert Gattermann, Oliver Schildgen Institut für Pathologie, Klinken der Stadt Köln gGmbH, Hospital of the Private University Witten ⁄ herdecke, Cologne, Germany. University Hospital Düsseldorf, Clinics for Hematology, Oncology, and Clinical Immunology, Düsseldorf, Germany. Hospital of the Private University Witten ⁄ herdecke, Fakultät für Gesundheit. Correspondence: Oliver Schildgen, Klinken der Stadt Köln gGmbH, Hospital of the Private University Witten/herdecke, Ostmerheimer Street 200, D-51109 Köln/Cologne, Germany. E-mail: [email protected]
منابع مشابه
Range Determination of Antigen Expression in Myeloid, Erythroid and Lymphoid Cell Lineages among Patients with Myelodysplastic Syndrome
Background: Myelodysplastic syndrome is a mixed clonal disorder of bone marrow progenitor cells. Understanding the pattern of the different lineage-specific, immature, and mature markers in myelodysplastic syndrome will help in setting-up the frame of reference to diagnose. Patients and Methods: We compared 60 bone marrow samples from 30 newly-diagnosed patients with myelodysplastic syndrome ...
متن کاملDetection of chromosome 20q deletions in bone marrow metaphases but not peripheral blood granulocytes in patients with myeloproliferative disorders or myelodysplastic syndromes.
Myeloproliferative disorders and myelodysplastic syndromes arise in multipotent progenitors and may be associated with chromosomal deletions that can be detected in peripheral blood granulocytes. We present here seven patients with myeloproliferative disorders or myelodysplastic syndromes in whom a deletion of the long arm of chromosome 20 was detectable by G-banding and/or fluorescence in situ...
متن کاملBone Marrow and Karyotype Findings of Patients with Pancytopenia in Southern Iran
Background: Pancytopenia is a manifestation of a wide range of disorders. The main prognostic factor for predicting outcome and response to treatment is based on the underlying cause. To detect the root cause of this problem, depending on other accompanied signs or symptoms, the need for bone marrow examination and other advanced work ups is different at least at the practical level. This study...
متن کاملLack of mutations of the human telomerase RNA gene (hTERC) in myelodysplastic syndrome.
Myelodysplastic syndrome (MDS), considered a pre-leukemic state, has recently been categorized as a subset of bone marrow failure syndromes. Unlike other subtypes of bone marrow failure syndromes, such as aplastic anemia or dyskeratosis congenita, little is known about genetic alterations of human telomerase in MDS, despite the fact that immune cells from patients with MDS frequently exhibit te...
متن کاملGene Expression and Methylation Pattern in HRK Apoptotic Gene in Myelodysplastic Syndrome
Myelodysplastic syndromes (MDSs) are a clonal bone marrow (BM) disease characterized by ineffective hematopoiesis, dysplastic maturation and progression to acute myeloid leukemia (AML). Methylation silencing of HRK has been found in several human malignancies. In this study, we explored the association of HRK methylation status with its expression, clinical parameters and MDS subtypes in MDS pa...
متن کامل